Navigation Links
SEI Defined Benefit Client Recognized With Leading Plan Design Award

OAKS, Pa., Oct. 14 /PRNewswire-FirstCall/ -- SEI (Nasdaq: SEIC) today announced that one of the company's institutional clients -- Meda Pharmaceuticals -- was recognized with the "Solutions Superstar" award by EmployersWeb. The award honors Meda for their outstanding and innovative defined benefit plan management including asset allocation changes and strategies aimed at matching the duration of invested assets with the plan's liabilities.

The Solutions Superstar for Most Innovative Plan Design from recognizes the strongest examples within corporate America of excellent plan design management. Meda was honored with the award, in part, because it successfully met its goal of providing stability and predictability to its plan contributions. The company implemented a dynamic investment management strategy designed to proactively evaluate asset allocations and utilize investment products aligned with their organizational goal of minimizing contribution volatility.

"Meda Pharmaceutical's pension and finance professionals should be commended for their strategic decision-making," said Roger Messina, Vice President and Managing Director, Relationship Management for SEI's Institutional Group. "Their vision for creating stability in their defined benefit pension plan is a model for others to follow. SEI is proud to partner with Meda in helping improve their financial management of the plan and we applaud their efforts."

For more information about the Solutions Superstars Awards, please visit

About SEI's Institutional Group

SEI's Institutional Group delivers integrated healthcare, retirement and nonprofit investment solutions to over 500 global institutional clients (of which 340 are U.S. based) in six different countries. SEI enables clients to meet financial objectives, reduce business risk, and fulfill their due diligence requirements through implemented fiduciary management strategies for defined benefit plans, defined contribution plans, endowments, foundations and other balance sheet assets. For more information, visit

About SEI

SEI (Nasdaq:SEIC) is a leading global provider of outsourced asset management, investment processing and investment operations solutions. The company's innovative solutions help corporations, financial institutions, financial advisors, and affluent families create and manage wealth. As of June 30, 2009, through its subsidiaries and partnerships in which the company has a significant interest, SEI administers $360 billion in mutual fund and pooled assets and manages $136 billion in assets. SEI serves clients, conducts or is registered to conduct business and/or operations, from numerous offices worldwide. For more information, visit


Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. URAC Introduces New Performance Measures and Reporting Standards for Pharmacy Benefit Management and Drug Therapy Management Accreditation
2. Urologists, Radiologists, Patients Benefit From New Clinical Prostate Visualization System
3. Anemic Patients With MDS Gain Long-Term Benefits From Erythropoietin and Myeloid Growth Factor Hormones
4. Yoga Benefits Back-Pain Patients
5. New Assessment Quantifies Risks and Benefits of Warfarin Treatment for Atrial Fibrillation
6. Teeth and Gums Also Benefit from the Healing Power of Aloe Vera
7. Glybera(TM) Shows Long-Term Health Benefits
8. Investigational Cancer Drug BSI-201 Showed Clinical Benefit in 62% of Patients with Triple-Negative Metastatic Breast Cancer and Significantly Prolonged Survival
9. MitraClip(R) Therapy Data Demonstrate Clinical Benefit in High-Risk Patients With Mitral Regurgitation
10. New MADIT II Clinical Data Analysis Shows Long-Term Survival Benefit for Implantable Defibrillator Therapy
11. New Body of Research Suggests Statin Use Benefits Multiple Areas of Urologic Health
Post Your Comments:
(Date:12/1/2015)... 2015  Athletic apparel company Tommie Copper ... pay $1.35 million to settle Federal Trade Commission ... compression clothing would relieve severe and chronic pain ... Tommie Copper,s proposed settlement ... its founder and chairman Thomas Kallish ...
(Date:12/1/2015)... and PITTSBURGH , Dec. ... announced that it expects to be the first to ... funded by international donors, TLE400 (Tenofovir Disoproxyl Fumarate 300 ... for $99 per patient, per year. Mylan partnered with ... The significantly reduced price could generate savings of tens ...
(Date:12/1/2015)... Virginia , 1 de diciembre de ... en tecnología para cuchillas de precisión, develó ... programa de identidad de marca. El nuevo ... el diseño y la ingeniería de productos ... la diferencia". ...
Breaking Medicine Technology:
(Date:12/1/2015)... ME (PRWEB) , ... December 01, 2015 , ... Royal ... reports a new study that found post-menopausal women who took the nutritional supplement creatine, ... than women who trained but did not take creatine. , The report is part ...
(Date:12/1/2015)... ... ... is the first health care provider in the region to offer the vBloc® Therapy ... vagal blocking therapy, delivered via the Maestro® System, for the treatment of adult patients over ... to 45 kg, or a BMI of at least 35 to 39.9 kg with a ...
(Date:12/1/2015)... , ... December 01, 2015 , ... ... oncology and hematology continuing medical education (CME), today announced that the first annual ... Hyatt New York. , “The prevention, detection and treatment of gastrointestinal cancers are ...
(Date:12/1/2015)... ... December 01, 2015 , ... Califia Farms , ... that its iconic bottle has won top honors in Beverage World Magazine’s Global Packaging ... also announced that it has been selected as a 2015 U.S.A. Taste Champion in ...
(Date:12/1/2015)... , ... December 01, 2015 , ... ... there are professionals who believe that with innovative technologies and under the right ... patient to get the benefit of a dual-approach to his or her therapeutic ...
Breaking Medicine News(10 mins):